VE-303
PureTech Health
[]
rajita menon did an excellent job presenting s work on dose-exposure and exposure-response relationships in the phase 2 consortium study of ve303 for prevention of rcdi #ddw2023 
Microbiome host. Founder & CEO @vedantabio